2,263
Views
117
CrossRef citations to date
0
Altmetric
Original Article

Saccharomyces boulardii'. A Review of an Innovative Biotherapeutic Agent

&
Pages 157-171 | Received 15 Apr 1993, Published online: 11 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (11)

Fereshteh Ansari, Shohre Alian Samakkhah, Ali Bahadori, Seyedeh Maedeh Jafari, Mojtaba Ziaee, Mohammad Taghi Khodayari & Hadi Pourjafar. (2023) Health-promoting properties of Saccharomyces cerevisiae var. boulardii as a probiotic; characteristics, isolation, and applications in dairy products. Critical Reviews in Food Science and Nutrition 63:4, pages 457-485.
Read now
Vandana Bali, Parmjit S. Panesar, Manab B. Bera & Reeba Panesar. (2015) Fructo-oligosaccharides: Production, Purification and Potential Applications. Critical Reviews in Food Science and Nutrition 55:11, pages 1475-1490.
Read now
Florinda Fratianni, Federica Cardinale, Ida Russo, Carmine Iuliano, Patrizio Tremonte, Raffaele Coppola & Filomena Nazzaro. (2014) Ability of synbiotic encapsulated Saccharomyces cerevisiae boulardii to grow in berry juice and to survive under simulated gastrointestinal conditions. Journal of Microencapsulation 31:3, pages 299-305.
Read now
Elisa Bertazzoni, Gianfranco Donelli, Tore Midtvedt, Jacques Nicoli & Yolanda Sanz. (2013) Probiotics and clinical effects: is the number what counts?. Journal of Chemotherapy 25:4, pages 193-212.
Read now
Rafael Zamora-Vega, José Luis Montañez-Soto, Héctor Eduardo Martínez-Flores, Rebeca Flores-Magallón, Carlos Víctor Muñoz-Ruiz, José Venegas-González & Teresita De Jesús Ariza Ortega. (2012) Effect of incorporating prebiotics in coating materials for the microencapsulation of Sacharomyces boulardii . International Journal of Food Sciences and Nutrition 63:8, pages 930-935.
Read now
Géraldine Hébrard, Valérie Hoffart, Eric Beyssac, Jean-Michel Cardot, Monique Alric & Muriel Subirade. (2010) Coated whey protein/alginate microparticles as oral controlled delivery systems for probiotic yeast. Journal of Microencapsulation 27:4, pages 292-302.
Read now
Ulrich Sonnenborn & Jürgen Schulze. (2009) The non-pathogenic Escherichia coli strain Nissle 1917 – features of a versatile probiotic. Microbial Ecology in Health and Disease 21:3-4, pages 122-158.
Read now
K. Rajkowska & A. Kunicka-Styczyńska. (2009) Phenotypic and Genotypic Characterization of Probiotic Yeasts. Biotechnology & Biotechnological Equipment 23:sup1, pages 662-665.
Read now
P. Periti & F. Tonelli. (2001) Preclinical and Clinical Pharmacology of Biotherapeutic Agents: Saccharomyces boulardii . Journal of Chemotherapy 13:5, pages 473-493.
Read now
Dieter H. M. Gröschel & B. Toye. (1996) Clostridium difficile Infection. Critical Reviews in Clinical Laboratory Sciences 33:3, pages 203-245.
Read now

Articles from other publishers (106)

Ismail GUMUSTOP & Fatih ORTAKCİ. (2022) Evaluating the microbial growth kinetics and artificial gastric digestion survival of a novel Pichia kudriavzevii FOL-04. Biotech Studies 31:1, pages 28-35.
Crossref
Cíntia Lacerda Ramos, Elizabethe Adriana Esteves, Rodrigo Pereira Prates, Lauane Gomes Moreno & Carina Sousa Santos. 2022. Probiotics in the Prevention and Management of Human Diseases. Probiotics in the Prevention and Management of Human Diseases 337 351 .
Zhanqiao Ding, Mingao Du, Fei Liu & Gongxin Li. (2021) Label-free rapid isolation of saccharomyces cerevisiae with optically induced dielectrophoresis-based automatic micromanipulation. Biomedical Microdevices 23:4.
Crossref
Hua Cao, Tuoyu Zhou, Haibo Tang, Pengya Feng, Gohar Ali, Pu Liu & Xiangkai Li. (2021) Genetically encoded probiotic EcN 1917 alleviates alcohol-induced acute liver injury and restore gut microbiota homeostasis. Journal of Functional Foods 85, pages 104661.
Crossref
Mariangela Rondanelli, Niccolò Miraglia, Pietro Putignano, Ignazio Castagliuolo, Paola Brun, Stefano Dall’Acqua, Gabriella Peroni, Milena Anna Faliva, Maurizio Naso, Mara Nichetti, Vittoria Infantino & Simone Perna. (2021) Effects of 60-Day Saccharomyces boulardii and Superoxide Dismutase Supplementation on Body Composition, Hunger Sensation, Pro/Antioxidant Ratio, Inflammation and Hormonal Lipo-Metabolic Biomarkers in Obese Adults: A Double-Blind, Placebo-Controlled Trial. Nutrients 13:8, pages 2512.
Crossref
Nilay Seyidoglu & Cenk Aydin. 2021. Saccharomyces. Saccharomyces.
Shaodan Sun, Yang Yang, Xiaojie Lin, Peiwen Chen, Liyan Ye, Liying Zeng, Qina Ye, Xiangna Yang, Jingtu Ceng, Jiayi Shan, Li Xie, Meirong Jiang, Fei Luo & Xiaogang Chen. (2021) Qiweibaizhu Decoction Treats Diarrheal Juvenile Rats by Modulating the Gut Microbiota, Short-Chain Fatty Acids, and the Mucus Barrier. Evidence-Based Complementary and Alternative Medicine 2021, pages 1-15.
Crossref
G.K.S. Prado, K.C. Torrinha, R.E. Cruz, A.B.B. Gonçalves, C.A.V. Silva, F.M.S. Oliveira, A.C. Nunes, M.A. Gomes & M.V. Caliari. (2020) Weissella paramesenteroides WpK4 ameliorate the experimental amoebic colitis by increasing the expression of MUC‐2 and the intestinal epithelial regeneration . Journal of Applied Microbiology 129:6, pages 1706-1719.
Crossref
Tibebe Lemma, Jin Wang, Kai Arstila, Vesa P. Hytönen & J. Jussi Toppari. (2019) Identifying yeasts using surface enhanced Raman spectroscopy. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 218, pages 299-307.
Crossref
Kevin D. Hyde, Jianchu Xu, Sylvie Rapior, Rajesh Jeewon, Saisamorn Lumyong, Allen Grace T. Niego, Pranami D. Abeywickrama, Janith V. S. Aluthmuhandiram, Rashika S. Brahamanage, Siraprapa Brooks, Amornrat Chaiyasen, K. W. Thilini Chethana, Putarak Chomnunti, Clara Chepkirui, Boontiya Chuankid, Nimali I. de Silva, Mingkwan Doilom, Craig Faulds, Eleni Gentekaki, Venkat Gopalan, Pattana Kakumyan, Dulanjalee Harishchandra, Hridya Hemachandran, Sinang Hongsanan, Anuruddha Karunarathna, Samantha C. Karunarathna, Sehroon Khan, Jaturong Kumla, Ruvishika S. Jayawardena, Jian-Kui Liu, Ningguo Liu, Thatsanee Luangharn, Allan Patrick G. Macabeo, Diana S. Marasinghe, Dan Meeks, Peter E. Mortimer, Peter Mueller, Sadia Nadir, Karaba N. Nataraja, Sureeporn Nontachaiyapoom, Meghan O’Brien, Watsana Penkhrue, Chayanard Phukhamsakda, Uma Shaanker Ramanan, Achala R. Rathnayaka, Resurreccion B. Sadaba, Birthe Sandargo, Binu C. Samarakoon, Danushka S. Tennakoon, Ramamoorthy Siva, Wasan Sriprom, T. S. Suryanarayanan, Kanaporn Sujarit, Nakarin Suwannarach, Thitipone Suwunwong, Benjarong Thongbai, Naritsada Thongklang, Deping Wei, S. Nuwanthika Wijesinghe, Jake Winiski, Jiye Yan, Erandi Yasanthika & Marc Stadler. (2019) The amazing potential of fungi: 50 ways we can exploit fungi industrially. Fungal Diversity 97:1, pages 1-136.
Crossref
Anum Khan, Ravi Jhaveri, Patrick C Seed & Mehreen Arshad. (2019) Update on Associated Risk Factors, Diagnosis, and Management of Recurrent Urinary Tract Infections in Children. Journal of the Pediatric Infectious Diseases Society 8:2, pages 152-159.
Crossref
B.A. Zullo & G. Ciafardini. (2019) Evaluation of physiological properties of yeast strains isolated from olive oil and their in vitro probiotic trait. Food Microbiology 78, pages 179-187.
Crossref
Bomba Dam, Arijit Misra & Sohini Banerjee. 2019. Oxidative Stress in Microbial Diseases. Oxidative Stress in Microbial Diseases 43 82 .
Pilar Fernandez-Pacheco, María Arévalo-Villena, Antonio Bevilacqua, Maria Rosaria Corbo & Ana Briones Pérez. (2018) Probiotic characteristics in Saccharomyces cerevisiae strains: Properties for application in food industries. LWT 97, pages 332-340.
Crossref
M.R.S. RibeiroD.R. OliveiraF.M.S. OliveiraM.V. CaliariF.S. MartinsJ.R. NicoliM.F. TorresM.E.R. AndradeV.N. CardosoM.A. Gomes. (2018) Effect of probiotic Saccharomyces boulardii in experimental giardiasis . Beneficial Microbes 9:5, pages 789-797.
Crossref
Alaa Niamah. (2017) Physicochemical and Microbial Characteristics of Yogurt with Added Saccharomyces Boulardii. Current Research in Nutrition and Food Science Journal 5:3, pages 300-307.
Crossref
Linda Wampach, Anna Heintz-Buschart, Angela Hogan, Emilie E. L. Muller, Shaman Narayanasamy, Cedric C. Laczny, Luisa W. Hugerth, Lutz Bindl, Jean Bottu, Anders F. Andersson, Carine de Beaufort & Paul Wilmes. (2017) Colonization and Succession within the Human Gut Microbiome by Archaea, Bacteria, and Microeukaryotes during the First Year of Life. Frontiers in Microbiology 8.
Crossref
I. Hamad, D. Raoult & F. Bittar. (2016) Repertory of eukaryotes (eukaryome) in the human gastrointestinal tract: taxonomy and detection methods. Parasite Immunology 38:1, pages 12-36.
Crossref
Tomás G. Villa, Angeles Sánchez-Pérez & Miguel Viñas. 2016. New Weapons to Control Bacterial Growth. New Weapons to Control Bacterial Growth 509 556 .
Nagendra P. Shah & Claude P. Champagne. 2015. Dairy Processing and Quality Assurance. Dairy Processing and Quality Assurance 235 265 .
M.R. Islam, J.S. Islam, G.M. Zatzman, M.A.H. Mughal & M. Safiur Rahman. 2015. The Greening of Pharmaceutical Engineering. The Greening of Pharmaceutical Engineering 713 772 .
Ryan Clanton, David Saucier, John Ford & Gamal Akabani. (2015) Microbial influences on hormesis, oncogenesis, and therapy: A review of the literature. Environmental Research 142, pages 239-256.
Crossref
Jean L. Schoeni. 2015. Compendium of Methods for the Microbiological Examination of Foods. Compendium of Methods for the Microbiological Examination of Foods.
Françoise Botterel, Cécile Angebault & Marie-Elisabeth Bougnoux. (2015) Le mycobiome humain : actualités et perspectives. Revue Francophone des Laboratoires 2015:469, pages 67-73.
Crossref
Diep Duongthingoc, Paul George, Elizabeth Gorczyca & Stefan Kasapis. (2014) Studies on the viability of Saccharomyces boulardii within microcapsules in relation to the thermomechanical properties of whey protein. Food Hydrocolloids 42, pages 232-238.
Crossref
Lauren E. Hudson, Milo B. Fasken, Courtney D. McDermott, Shonna M. McBride, Emily G. Kuiper, David B. Guiliano, Anita H. Corbett & Tracey J. Lamb. (2014) Functional Heterologous Protein Expression by Genetically Engineered Probiotic Yeast Saccharomyces boulardii. PLoS ONE 9:11, pages e112660.
Crossref
Laura Wegener Parfrey, William A. Walters, Christian L. Lauber, Jose C. Clemente, Donna Berg-Lyons, Clotilde Teiling, Chinnappa Kodira, Mohammed Mohiuddin, Julie Brunelle, Mark Driscoll, Noah Fierer, Jack A. Gilbert & Rob Knight. (2014) Communities of microbial eukaryotes in the mammalian gut within the context of environmental eukaryotic diversity. Frontiers in Microbiology 5.
Crossref
Gustavo Almeida Bastos, Elinalva Maciel Paulo & Ana Cristina Nascimento Chiaradia. (2014) Aceitabilidade de barra de cereais potencialmente probiótica. Brazilian Journal of Food Technology 17:2, pages 113-120.
Crossref
Lijia Cui, Alison Morris & Elodie Ghedin. (2013) The human mycobiome in health and disease. Genome Medicine 5:7, pages 63.
Crossref
Gerald Friedman. (2012) The Role of Probiotics in the Prevention and Treatment of Antibiotic-Associated Diarrhea and Clostridium Difficile Colitis. Gastroenterology Clinics of North America 41:4, pages 763-779.
Crossref
M. Ratna Sudha, S. Bhonagiri & M. Asin Kumar. (2012) Oral consumption of potential probiotic Saccharomyces boulardii strain Unique 28 in patients with acute diarrhoea: a clinical report . Beneficial Microbes 3:2, pages 145-150.
Crossref
M. Ratna Sudha. (2011) Safety assessment studies of probiotic Saccharomyces boulardii strain Unique 28 in Sprague-Dawley rats . Beneficial Microbes 2:3, pages 221-227.
Crossref
Kelly Galvin & Madelaine Bishop. 2011. Case Studies for Complementary Therapists. Case Studies for Complementary Therapists 9 42 .
L.M.E. Vanhee, F. Goemé, H.J. Nelis & T. Coenye. (2010) Quality control of fifteen probiotic products containing Saccharomyces boulardii. Journal of Applied Microbiology, pages no-no.
Crossref
Jean-François Bisson, Sophie Hidalgo, Pascale Rozan & Michaël Messaoudi. (2009) Preventive Effects of Different Probiotic Formulations on Travelers’ Diarrhea Model in Wistar Rats. Digestive Diseases and Sciences 55:4, pages 911-919.
Crossref
Michael de Vrese & B. Offick. 2010. Bioactive Foods in Promoting Health. Bioactive Foods in Promoting Health 205 227 .
Ping-Nan Sun, Xue-Cheng Zhang, Yun-Song Chen & Xiao-Nan Zang. (2010) Application of the yeast-surface-display system for orally administered salmon calcitonin and safety assessment. Biotechnology Progress, pages NA-NA.
Crossref
Fabiana C. P. Tiago, Flaviano S. Martins, Carlos A. Rosa, Regina M. D. Nardi, Denise C. Cara & Jacques R. Nicoli. (2008) Physiological characterization of non-Saccharomyces yeasts from agro-industrial and environmental origins with possible probiotic function. World Journal of Microbiology and Biotechnology 25:4, pages 657-666.
Crossref
T. Deak. 2009. Yeast Biotechnology: Diversity and Applications. Yeast Biotechnology: Diversity and Applications 151 168 .
Jung-Gu Lim & Hyo-Sang Jin. (2008) Heterologous expression of cholera toxin B subunit in Saccharomyces cerevisiae. Biotechnology and Bioprocess Engineering 13:5, pages 598-605.
Crossref
Michael Bolton, Ariane van der Straten & Craig R. Cohen. (2008) Probiotics: Potential to Prevent HIV and Sexually Transmitted Infections in Women. Sexually Transmitted Diseases 35:3, pages 214-225.
Crossref
Seung-Moon Park, Ae-Young Mo, Jung-Gu Lim, Hea-Jong Chung, Tae-Geum Kim, Kang-Ju Kim, Dong-Ha Cho, Moon-Sik Yang & Dae-Hyuk Kim. (2007) Surface displayed expression of a neutralizing epitope of spike protein from a Korean strain of porcine epidemic diarrhea virus. Biotechnology and Bioprocess Engineering 12:6, pages 690-695.
Crossref
S. A. Keyser, J. P. McMeniman, D. R. Smith, J. C. MacDonald & M. L. Galyean. (2007) Effects of Saccharomyces cerevisiae subspecies boulardii CNCM I-1079 on feed intake by healthy beef cattle treated with florfenicol and on health and performance of newly received beef heifers1. Journal of Animal Science 85:5, pages 1264-1273.
Crossref
Flaviano S. Martins, Ana Cristina P. Rodrigues, Fabiana C. P. Tiago, Francisco J. Penna, Carlos A. Rosa, Rosa M. E. Arantes, Regina M. D. Nardi, Maria J. Neves & Jacques R. Nicoli. (2007) Saccharomyces cerevisiae strain 905 reduces the translocation of Salmonella enterica serotype Typhimurium and stimulates the immune system in gnotobiotic and conventional mice. Journal of Medical Microbiology 56:3, pages 352-359.
Crossref
Leo Galland. 2007. Integrative Medicine. Integrative Medicine 541 554 .
Yann Waché, Françoise Auffray, François-Joël Gatesoupe, José Zambonino, Vincent Gayet, Laurent Labbé & Claire Quentel. (2006) Cross effects of the strain of dietary Saccharomyces cerevisiae and rearing conditions on the onset of intestinal microbiota and digestive enzymes in rainbow trout, Onchorhynchus mykiss, fry. Aquaculture 258:1-4, pages 470-478.
Crossref
Ipek Akil, Ozge Yilmaz, Semra Kurutepe, Kenan Degerli & Salih Kavukcu. (2006) Influence of oral intake of Saccharomyces boulardii on Escherichia coli in enteric flora. Pediatric Nephrology 21:6, pages 807-810.
Crossref
Abd El-Zaher M.A. Mustafa .Abdelfattah Badr .Mohammed A. El-Galaly .Ahmed A. Mobarak .Mervet G. Hassan .. (2006) Genetic Diversity among Ocimum Populations in Egypt as Reflected by Morphological, Seed Proteins and Isozyme Polymorphism. International Journal of Botany 2:3, pages 261-269.
Crossref
Mehmet Faruk Geyik, Mustafa Aldemir, Salih Hosoglu, Celal Ayaz, Selda Satilmis, Huseyin Buyukbayram & Omer Faruk Kokoglu. (2006) The Effects of Saccharomyces boulardii on Bacterial Translocation in Rats with Obstructive Jaundice . The Annals of The Royal College of Surgeons of England 88:2, pages 176-180.
Crossref
AG Billoo. (2006) Role of a probiotic (Saccharomyces boulardii) in management and prevention of diarrhoea. World Journal of Gastroenterology 12:28, pages 4557.
Crossref
Pietro Buzzini & Ann Vaughan-Martini. 2006. Biodiversity and Ecophysiology of Yeasts. Biodiversity and Ecophysiology of Yeasts 533 559 .
Deniz G??ney Duman, Serhat Bor, ??mer ??z??temiz, T??lin ??ahin, Dilek O??uz, Fahri I??tan, T??mer Vural, Macit Sandkci, Fatih I??ksal, ??lkay ??im??ek, M??jde Soyt??rk, Serap Arslan, B??lent Sivri, ??rfan Soykan, Ay??eg??l Temizkan, Fatih Be????k, Sabahattin Kaymako??lu & Cem Kalayc. (2005) Efficacy and safety of Saccharomyces boulardii in prevention of antibiotic-associated diarrhoea due to Helicobacterpylori eradication. European Journal of Gastroenterology & Hepatology 17:12, pages 1357-1361.
Crossref
Philippe Girard, Yannick Pansart & Jean-Marie Gillardin. (2005) Inducible nitric oxide synthase involvement in the mechanism of action of Saccharomyces boulardii in castor oil-induced diarrhoea in rats. Nitric Oxide 13:3, pages 163-169.
Crossref
Philippe Girard, Yannick Pansart, Marie-Claude Coppe & Jean-Marie Gillardin. (2005) Saccharomyces boulardii Inhibits Water and Electrolytes Changes Induced by Castor Oil in the Rat Colon. Digestive Diseases and Sciences 50:11, pages 2183-2190.
Crossref
Lynne McFarland & Gary Elmer. 2005. Probiotics in Food Safety and Human Health. Probiotics in Food Safety and Human Health 109 138 .
Anne M. Desrochers, Brett A. Dolente, Marie-France Roy, Raymond Boston & Sharon Carlisle. (2005) Efficacy of Saccharomyces boulardii for treatment of horses with acute enterocolitis. Journal of the American Veterinary Medical Association 227:6, pages 954-959.
Crossref
Jean-Paul Buts & Paul Bernasconi. (2005) Saccharomyces boulardii: Basic Science and Clinical Applications in Gastroenterology. Gastroenterology Clinics of North America 34:3, pages 515-532.
Crossref
Klibs N. Galvão, José E.P. Santos, Anelis Coscioni, Marcos Villaseñor, William M. Sischo & Anna Catharina B. Berge. (2005) Effect of feeding live yeast products to calves with failure of passive transfer on performance and patterns of antibiotic resistance in fecal Escherichia coli . Reproduction Nutrition Development 45:4, pages 427-440.
Crossref
Flariano S. Martins, Regina M. D. Nardi, Rosa M. E. Arantes, Carlos A. Rosa, Maria J. Neves & Jacques R. Nicoli. (2005) Screening of yeasts as probiotic based on capacities to colonize the gastrointestinal tract and to protect against enteropathogen challenge in mice. The Journal of General and Applied Microbiology 51:2, pages 83-92.
Crossref
E.I. Psomas, D.J. Fletouris, E. Litopoulou-Tzanetaki & N. Tzanetakis. (2003) Assimilation of Cholesterol by Yeast Strains Isolated from Infant Feces and Feta Cheese. Journal of Dairy Science 86:11, pages 3416-3422.
Crossref
C Costalos, V Skouteri, A Gounaris, S Sevastiadou, A Triandafilidou, C Ekonomidou, F Kontaxaki & V Petrochilou. (2003) Enteral feeding of premature infants with Saccharomyces boulardii. Early Human Development 74:2, pages 89-96.
Crossref
Przemyslaw Jan TomasikPiotr Tomasik. (2003) Probiotics and Prebiotics. Cereal Chemistry Journal 80:2, pages 113-117.
Crossref
Stephanie Dahan, Guillaume Dalmasso, Veronique Imbert, Jean-Francois Peyron, Patrick Rampal & Dorota Czerucka. (2003) Saccharomyces boulardii Interferes with Enterohemorrhagic Escherichia coli-Induced Signaling Pathways in T84 Cells. Infection and Immunity 71:2, pages 766-773.
Crossref
Alis van der Aa Kühle & Lene Jespersen. (2003) The Taxonomic Position of Saccharomyces boulardii as Evaluated by Sequence Analysis of the D1/D2 Domain of 26S rDNA, the ITS1-5.8S rDNA-ITS2 Region and the Mitochondrial Cytochrome-c Oxidase II Gene. Systematic and Applied Microbiology 26:4, pages 564-571.
Crossref
Ruth Chadwick, S. Henson, B. Moseley, G. Koenen, M. Liakopoulos, C. Midden, A. Palou, G. Rechkemmer, D. Schröder & A. WrightRuth Chadwick, S. Henson, B. Moseley, G. Koenen, M. Liakopoulos, C. Midden, A. Palou, G. Rechkemmer, D. Schröder & A. Wright. 2003. Functional Foods. Functional Foods 161 179 .
P. Periti & F. Tonelli. (2002) Biotherapeutics and biotherapy of surgical enteropathies. Digestive and Liver Disease 34, pages S87-S97.
Crossref
Albert Tasteyre, Marie-Claude Barc, Tuomo Karjalainen, Pierre Bourlioux & Anne Collignon. (2002) Inhibition of in vitro cell adherence of Clostridium difficile by Saccharomyces boulardii. Microbial Pathogenesis 32:5, pages 219-225.
Crossref
Timothy Sentongo & Maria R Mascarenhas. (2002) Newer components of enteral formulas. Pediatric Clinics of North America 49:1, pages 113-125.
Crossref
MUSTAFA ALDEMIR, Ö. FARUK KÖKOGLU, M. FARUK GEYIK & HÜSEYIN BÜYÜKBAYRAM. (2002) Effects of Octreotide Acetate and Saccharomyces Boulardii on Bacterial Translocation in an Experimental Intestinal Loop Obstruction Model of Rats.. The Tohoku Journal of Experimental Medicine 198:1, pages 1-9.
Crossref
A Lourens-Hattingh & B.C Viljoen. (2001) Growth and survival of a probiotic yeast in dairy products. Food Research International 34:9, pages 791-796.
Crossref
Carlos LifschitzYvan Vandenplas. 2001. Pediatric Gastroenterology and Nutrition in Clinical Practice. Pediatric Gastroenterology and Nutrition in Clinical Practice 137 159 .
Stéphanie Blanquet, Sylvie Marol-Bonnin, Eric Beyssac, Denis Pompon, Michel Renaud & Monique Alric. (2001) The ‘biodrug’ concept: an innovative approach to therapy. Trends in Biotechnology 19:10, pages 393-400.
Crossref
Gary W. Elmer & Lynne V. McFarland. (2001) BIOTHERAPEUTIC AGENTS IN THE TREATMENT OF INFECTIOUS DIARRHEA. Gastroenterology Clinics of North America 30:3, pages 837-854.
Crossref
M. I. Alvarez-Olmos & R. A. Oberhelman. (2001) Probiotic Agents and Infectious Diseases: A Modern Perspective on a Traditional Therapy. Clinical Infectious Diseases 32:11, pages 1567-1576.
Crossref
Kathryn A. Kollman, Olivier Goulet & Jon A. Vanderhoof. (2001) Saccharomyces boulardii Does Not Stimulate Mucosal Hyperplasia after Intestinal Resection in the Rat. Journal of Pediatric Gastroenterology and Nutrition 32:4, pages 454-457.
Crossref
Jean Pierre Cézard, Jean François Duhamel, Martine Meyer, Isabelle Pharaon, Marc Bellaiche, Chantal Maurage, Jean Louis Ginies, Jean Michel Vaillant, Jean Philippe Girardet, Thierry Lamireau, Alain Poujol, Alain Morali, Jacques Sarles, Jean Pierre Olives, Caroline Whately–Smith, Jeanne Marie Lecomte & Sylvie Audrain. (2001) Efficacy and tolerability of racecadotril in acute diarrhea in children. Gastroenterology 120:4, pages 799-805.
Crossref
M. H. Wilcox & J. Dave. (2001) Treatment options in Clostridium difficile infection. Reviews in Medical Microbiology 12:1, pages 21-28.
Crossref
D. Czerucka, S. Dahan, B. Mograbi, B. Rossi & P. Rampal. (2000) Saccharomyces boulardii Preserves the Barrier Function and Modulates the Signal Transduction Pathway Induced in Enteropathogenic Escherichia coli-Infected T84 Cells. Infection and Immunity 68:10, pages 5998-6004.
Crossref
Christina M. Surawicz, Lynne V. McFarland, Richard N. Greenberg, Moshe Rubin, Robert Fekety, Maury E. Mulligan, Reuben J. Garcia, Sally Brandmarker, Karen Bowen, Delia Borjal & Gary W. Elmer. (2000) The Search for a Better Treatment for Recurrent Clostridium difficile Disease: Use of High‐Dose Vancomycin Combined with Saccharomyces boulardii . Clinical Infectious Diseases 31:4, pages 1012-1017.
Crossref
A. Andremont. (2000) Impact des antibiotiques sur l'écologie de la résistance bactérienne: rôle du tube digestif. Médecine et Maladies Infectieuses 30, pages s178-s184.
Crossref
Gedek. (2002) Adherence of Escherichia coli serogroup 0 157 and the Salmonella Typhimurium mutant DT 104 to the surface of Saccharomyces boulardii . Mycoses 42:4, pages 261-264.
Crossref
Lynne V. McFarland. (1999) Microecologic approaches for traveler’s diarrhea, antibiotic-associated diarrhea, and acute pediatric diarrhea. Current Gastroenterology Reports 1:4, pages 301-307.
Crossref
Yvan Vandenplas. (1999) Bacteria and yeasts in the treatment of acute and chronic infectious diarrhea. Part II: Yeasts. Clinical Microbiology and Infection 5:7, pages 389-395.
Crossref
Maurice Madeo, Maggie Whitlock & Colin R. Martin. (1999) A randomized controlledtrial comparing Lactobacillus combined with Bifidobacterium bifidum against fructo-oligosaccharides in reducing the incidence of antibiotic-associated diarrhoea: a preliminary investigation. Clinical Effectiveness in Nursing 3:2, pages 83-87.
Crossref
Renaud Piarroux, Laurence Millon, Karine Bardonnet, Odile Vagner & Hélène Koenig. (1999) Are live saccharom yces yeasts harmful to patients?. The Lancet 353:9167, pages 1851-1852.
Crossref
Lynne V. McFarland. 1999. Biotherapeutic Agents and Infectious Diseases. Biotherapeutic Agents and Infectious Diseases 159 193 .
Steven W. Martin, Anne C. Heatherington & Gary W. Elmer. 1999. Biotherapeutic Agents and Infectious Diseases. Biotherapeutic Agents and Infectious Diseases 47 84 .
Jean-Paul Buts. 1999. Biotherapeutic Agents and Infectious Diseases. Biotherapeutic Agents and Infectious Diseases 27 46 .
Christina M. Surawicz & Lynne V. McFarland. 1999. Biotherapeutic Agents and Infectious Diseases. Biotherapeutic Agents and Infectious Diseases 263 268 .
Jon A. Vanderhoof & Rosemary J. Young. (1998) Use of Probiotics in Childhood Gastrointestinal Disorders. Journal of Pediatric Gastroenterology & Nutrition 27:3, pages 323-332.
Crossref
S.J. Lewis, L.F. Potts & R.E. Barry. (1998) The lack of therapeutic effect of Saccharomyces boulardii in the prevention of antibiotic-related diarrhoea in elderly patients. Journal of Infection 36:2, pages 171-174.
Crossref
Rogelio L. Brandão, Ieso M. Castro, Eduardo A. Bambirra, Sheila C. Amaral, Luciano G. Fietto, Maria José M. Tropia, Maria José Neves, Raquel G. Dos Santos, Newton C. M. Gomes & Jacques R. Nicoli. (1998) Intracellular Signal Triggered by Cholera Toxin inSaccharomyces boulardii and Saccharomyces cerevisiae. Applied and Environmental Microbiology 64:2, pages 564-568.
Crossref
Philippe MARTEAU & Tuula VESA. (1998) Pharmacokinetics of Probiotics and Biotherapeutic Agents in Humans. Bioscience and Microflora 17:1, pages 1-6.
Crossref
. 1998. The Yeasts. The Yeasts 955 1016 .
Markus Sauerborn, Petra Leukel & Christoph Eichel-Streiber. (2006) The C-terminal ligand-binding domain of Clostridium difficile toxin A (TcdA) abrogates TcdA-specific binding to cells and prevents mouse lethality. FEMS Microbiology Letters 155:1, pages 45-54.
Crossref
L.V. McFarland & G.W. Elmer. (1997) Pharmaceutical Probiotics for the Treatment of Anaerobic and Other Infections. Anaerobe 3:2-3, pages 73-78.
Crossref
G. Corthier. 1997. Probiotics 2. Probiotics 2 40 64 .
Philip M. Sherman, Martin Petric & Mitchell B. Cohen. (1996) INFECTIOUS GASTROENTEROCOLITIDES IN CHILDREN. Pediatric Clinics of North America 43:2, pages 391-407.
Crossref
M.P. Schreuder, C. Deen, W.J.A. Boersma, P.H. Pouwels & F.M. Klis. (1996) Yeast expressing hepatitis B virus surface antigen determinants on its surface: implications for a possible oral vaccine. Vaccine 14:5, pages 383-388.
Crossref
Maarten P. Schreuder, Arno T.A. Mooren, Holger Y. Toschka, C. Theo Verrips & Frans M. Klis. (1996) Immobilizing proteins on the surface of yeast cells. Trends in Biotechnology 14:4, pages 115-120.
Crossref
Clayton L Golledge & Thomas V Riley. (1996) “Natural” therapy for infectious diseases. Medical Journal of Australia 164:2, pages 94-95.
Crossref
C. Boucaud, K. Berrada & P. Bouletreau. (1996) Septicémie à Saccharomyces boulardii après administration orale d'ultra-levure. Réanimation Urgences 5:5, pages 665.
Crossref
Christine Roffe. (1996) Biotherapy for antibiotic-associated and other diarrhoeas. Journal of Infection 32:1, pages 1-10.
Crossref
Robert Fekety. 1996. Ökosystem Darm Special. Ökosystem Darm Special 117 128 .
. (1994) Clostridium difficile Colitis. New England Journal of Medicine 330:24, pages 1754-1755.
Crossref
Jos H.J. Huis in't Veld, Robert Havenaar & Philippe Marteau. (1994) Establishing a scientific basis for probiotic R&D. Trends in Biotechnology 12:1, pages 6-8.
Crossref